| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 16.82▼ | 16.83▼ | 16.82▼ | 16.80▲ | 16.69▲ |
| MA10 | 16.83▼ | 16.82▼ | 16.81▲ | 16.83▲ | 16.40▲ |
| MA20 | 16.82▲ | 16.82 | 16.80▲ | 16.67▲ | 16.09▲ |
| MA50 | 16.80▲ | 16.82▼ | 16.76▲ | 16.30▲ | 16.47▲ |
| MA100 | 16.79▲ | 16.64▲ | 16.53▲ | 16.08▲ | 16.54▲ |
| MA200 | 16.53▲ | 16.37▲ | 16.25▲ | 16.28▲ | 16.65▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.001▲ | -0.002▼ | -0.010▼ | 0.142▲ |
| RSI | 50.736▲ | 51.616▲ | 54.403▲ | 68.525▲ | 61.928▲ |
| STOCH | 46.574 | 81.250▲ | 53.423 | 63.328 | 88.795▲ |
| WILL %R | -37.500 | -37.500 | -37.500 | -22.727▲ | -7.959▲ |
| CCI | -27.874 | -22.485 | 6.711 | 54.940 | 136.586▲ |
|
Tuesday, September 30, 2025 07:41 AM
Eupraxia's Cohort 9 RESOLVE trial data showed durable remission, improved tissue health, and strong safety, supporting Phase 2b expansion.
|
|
Thursday, September 25, 2025 01:43 PM
The nine John Hancock closed-end funds listed below announced today that each fund's Annual Meeting of Shareholders ("Annual Meeting") will be held on February 17, 2026, at 2:00 p.m., Eastern Time, at ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/25 | 16.83 | 16.88 | 16.78 | 16.85 | 52,008 |
| 29/09/25 | 16.83 | 16.85 | 16.77 | 16.78 | 62,478 |
| 26/09/25 | 16.80 | 16.86 | 16.77 | 16.80 | 33,500 |
| 25/09/25 | 16.74 | 16.83 | 16.65 | 16.75 | 61,000 |
| 24/09/25 | 16.85 | 16.88 | 16.81 | 16.84 | 25,400 |
| 23/09/25 | 16.90 | 16.90 | 16.81 | 16.88 | 20,000 |
| 22/09/25 | 16.87 | 16.92 | 16.80 | 16.90 | 49,800 |
| 19/09/25 | 16.89 | 16.95 | 16.84 | 16.87 | 59,000 |
| 18/09/25 | 16.78 | 16.88 | 16.70 | 16.87 | 47,700 |
| 17/09/25 | 16.65 | 16.79 | 16.65 | 16.77 | 45,400 |
|
|
||||
|
|
||||
|
|